{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:47:56Z","timestamp":1787032076386,"version":"build-2736575974"},"reference-count":25,"publisher":"Japan Atherosclerosis Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2010]]},"DOI":"10.5551\/jat.3293","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T09:45:38Z","timestamp":1308217538000},"page":"730-739","source":"Crossref","is-referenced-by-count":15,"title":["Antiplatelet activity and structure-activity relationship study of Pyrazolopyridine Derivatives as potential series for treating thrombotic diseases"],"prefix":"10.5551","volume":"17","author":[{"given":"RB","family":"Geraldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ML","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LRS","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MAF","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PA","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MB","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MG","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LM","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ACC","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MV","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CR","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HC","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.2174\/187152508784871972"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.07.020"},{"key":"3","unstructured":"3) Fuster V, Baldimon L, Baldimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute cor-onary syndromes. Part I. N Engl J Med 1992; 326: 242-250"},{"key":"4","unstructured":"4) Fuster V, Baldimon L, Baldimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute cor-onary syndromes. Part II. N Engl J Med 1992; 326: 310-318"},{"key":"5","unstructured":"5) World Health Organization (WHO) http:\/\/www.who.int\/cardiovascular_diseases\/en\/. Accessed in 2008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Zimmermann N and Hohlfeld T: Clinical implications of aspirin resistance. Thromb Haemost 2008; 100: 379-390","DOI":"10.1160\/TH08-01-0056"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-006-0063-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Algra A, De Schryver EL, van Gijn J, Kappelle LJ, Koud-staal PJ: Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient isch-aemic attack or minor stroke of presumed arterial origin. Cochrane Database Syst Rev 2006; 3: CD001342","DOI":"10.1002\/14651858.CD001342.pub2"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0b013e318189a701"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Krötz F, Sohn HY and Klauss V: Antiplatelet drugs in car-diological practice: established strategies and new devel-opments. Vasc Health Risk Manag 2008; 4: 637-645","DOI":"10.2147\/VHRM.S2691"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-4949.2008.00198.x"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.06.006"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2006.09.067"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2007.03.032"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.10.085"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Pinheiro LC, Abreu PA, Afonso IF, Leal B, Corrêa LC, Borges JC, Marques IP, Lourenço AL, Sathler P, Dos San-tos AL, Medeiros CA, Cabral LM, Júnior ML, Romeiro GA, Ferreira VF, Rodrigues CR, Castro HC, Bernardino AM: Identification of a potential lead structure for de-signing new antimicrobials to treat infections caused by Staphylococcus epidermidis-resistant strains. Curr Micro-biol 2008; 57: 463-468","DOI":"10.1007\/s00284-008-9234-5"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20425"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2007.09.032"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00129-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tekto IV: Computing chemistry on the web. Drug Discov Today 2005; 22: 1497-1500","DOI":"10.1016\/S1359-6446(05)03584-1"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1999.00570.x"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.150474"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Cross PE, Dickinson RP: Thromboxane synthetase inhib-itors and antagonists. Ann Rep Med Chem 1987; 22: 95-105","DOI":"10.1016\/S0065-7743(08)61158-6"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2008.01.001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Lewis GP, Watts IS: Prostaglandin endoperoxides, throm-boxane A2 and adenosine diphosphate in collagen-in-duced aggregation of rabbit platelets. Br J Pharm 1982; 75: 623-631","DOI":"10.1111\/j.1476-5381.1982.tb09183.x"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T14:44:39Z","timestamp":1621521879000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jat\/17\/7\/17_3293\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.3293","relation":{},"ISSN":["1880-3873","1340-3478"],"issn-type":[{"value":"1880-3873","type":"electronic"},{"value":"1340-3478","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}